Testing effectiveness (Phase 2)Study completedNCT03099785
What this trial is testing
Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Cosmo Technologies Ltd 279